LifeStance Q2 FY26 net income turns to USD 23.6 million; revenue rises 26% to USD 435.4 million
LFST•LifeStance reports higher revenue, income and adjusted EBITDA in Q2 2026
- LifeStance posted Q2 2026 revenue of $435.4 million, up 26% from the prior-year quarter.
- Net income swung to $23.6 million; operating income rose to $30.7 million.
- Non-GAAP adjusted EBITDA climbed to $66 million, more than doubled from the prior-year quarter.
- Clinician base increased 11% to 8,542; visit volumes rose 19% to 2,600,000.
- Raised FY 2026 outlook to revenue of $1.685 billion-$1.725 billion; announced a $100 million share repurchase program.
Related News
Mastech Digital Q2 FY26 GAAP net income turns to loss of $100,000; revenue drops 15.6% to $41.45 million year over year
MHH•
Opus Genetics Q2 FY26 net loss widens to $8.1 million; revenue drops to $755,000
IRD•
